Carlos Sanabria

1.2k total citations · 1 hit paper
18 papers, 861 citations indexed

About

Carlos Sanabria is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Dermatology. According to data from OpenAlex, Carlos Sanabria has authored 18 papers receiving a total of 861 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 4 papers in Molecular Biology and 3 papers in Dermatology. Recurrent topics in Carlos Sanabria's work include Cardiac electrophysiology and arrhythmias (4 papers), Bee Products Chemical Analysis (3 papers) and Skin Protection and Aging (3 papers). Carlos Sanabria is often cited by papers focused on Cardiac electrophysiology and arrhythmias (4 papers), Bee Products Chemical Analysis (3 papers) and Skin Protection and Aging (3 papers). Carlos Sanabria collaborates with scholars based in United States, Sweden and Netherlands. Carlos Sanabria's co-authors include David G. Strauss, Murali K. Matta, Jeffry Florian, S. Kemp, José Vicente, Vikram Patel, Robbert Zusterzeel, Lars Johannesen, Norman Stockbridge and Jay W. Mason and has published in prestigious journals such as JAMA, Clinical Pharmacology & Therapeutics and British Journal of Anaesthesia.

In The Last Decade

Carlos Sanabria

15 papers receiving 832 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Sunscreen Application Under Maximal Use Conditions on Plasma Concentration of Sunscreen Active Ingredients

2019 215 citations Murali K. Matta, Robbert Zusterzeel et al. JAMA profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carlos Sanabria United States	10	327	285	208	126	58	18	861
Robbert Zusterzeel United States	13	468 1.4×	281 1.0×	98 0.5×	131 1.0×	17 0.3×	29	982
Anna Lanzoni Italy	15	33 0.1×	111 0.4×	130 0.6×	42 0.3×	34 0.6×	29	658
Claudia Torricelli Italy	13	21 0.1×	48 0.2×	299 1.4×	94 0.7×	25 0.4×	21	780
M.J. Bartek United States	5	59 0.2×	189 0.7×	59 0.3×	45 0.4×	10 0.2×	10	489
J. E. Whitney United States	12	43 0.1×	269 0.9×	262 1.3×	17 0.1×	18 0.3×	31	1.0k
Stephen Krop United States	13	149 0.5×	22 0.1×	112 0.5×	26 0.2×	66 1.1×	36	578
George Lagoumintzis Greece	17	29 0.1×	18 0.1×	408 2.0×	64 0.5×	63 1.1×	40	923
Shajrul Amin India	15	41 0.1×	26 0.1×	197 0.9×	12 0.1×	15 0.3×	46	694
Christian Narkowicz Australia	17	17 0.1×	47 0.2×	198 1.0×	17 0.1×	14 0.2×	40	905
D. Pelling United Kingdom	12	47 0.1×	15 0.1×	116 0.6×	88 0.7×	80 1.4×	27	558

Countries citing papers authored by Carlos Sanabria

Since Specialization

Citations

This map shows the geographic impact of Carlos Sanabria's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos Sanabria with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos Sanabria more than expected).

Fields of papers citing papers by Carlos Sanabria

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlos Sanabria. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos Sanabria. The network helps show where Carlos Sanabria may publish in the future.

Co-authorship network of co-authors of Carlos Sanabria

This figure shows the co-authorship network connecting the top 25 collaborators of Carlos Sanabria. A scholar is included among the top collaborators of Carlos Sanabria based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlos Sanabria. Carlos Sanabria is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Florian, Jeffry, Rutger van der Schrier, Michael C. Davis, et al.. (2025). Effect of midazolam co-administered with oxycodone on ventilation: a randomised clinical trial in healthy volunteers. British Journal of Anaesthesia. 134(4). 1170–1180.

Darwish, Mona, et al.. (2025). Assessing the effects of trofinetide on QTc interval, safety and tolerability, and pharmacokinetics in healthy adults. 5(1).

Sanabria, Carlos, et al.. (2024). An Interdisciplinary Approach to DNA Analysis. Forensic Science International Synergy. 8. 100494–100494.

D’Ruiz, Carl D., et al.. (2023). Preliminary clinical pharmacokinetic evaluation of bemotrizinol - A new sunscreen active ingredient being considered for inclusion under FDA's over-the-counter (OTC) sunscreen monograph. Regulatory Toxicology and Pharmacology. 139. 105344–105344. 12 indexed citations

Hyland, Paula L., Barry A. Rosenzweig, Yan Guo, et al.. (2022). Evaluating the Utility of Proteomics for the Identification of Circulating Pharmacodynamic Biomarkers of IFNβ‐1a Biologics. Clinical Pharmacology & Therapeutics. 113(1). 98–107. 3 indexed citations

Florian, Jeffry, Sarah J. Schrieber, Murali K. Matta, et al.. (2022). Considerations for Use of Pharmacodynamic Biomarkers to Support Biosimilar Development – (III) A Randomized Trial with Interferon Beta‐1a Products. Clinical Pharmacology & Therapeutics. 113(2). 339–348. 5 indexed citations

Matta, Murali K., Jeffry Florian, Robbert Zusterzeel, et al.. (2020). Effect of Sunscreen Application on Plasma Concentration of Sunscreen Active Ingredients. JAMA. 323(3). 256–256. 183 indexed citations

Sanabria, Carlos, Elizabeth Migoya, Jay W. Mason, et al.. (2019). Effect of Cefiderocol, a Siderophore Cephalosporin, on QT/QTc Interval in Healthy Adult Subjects. Clinical Therapeutics. 41(9). 1724–1736.e4. 22 indexed citations

Matta, Murali K., Robbert Zusterzeel, Nageswara Rao Pilli, et al.. (2019). Effect of Sunscreen Application Under Maximal Use Conditions on Plasma Concentration of Sunscreen Active Ingredients. JAMA. 321(21). 2082–2082. 215 indexed citations breakdown →

10.

Houck, David R., et al.. (2018). NYX‐2925, A Novel N‐methyl‐D‐aspartate Receptor Modulator: A First‐in‐Human, Randomized, Double‐blind Study of Safety and Pharmacokinetics in Adults. Clinical and Translational Science. 12(2). 164–171. 16 indexed citations

11.

Vicente, José, Robbert Zusterzeel, Lars Johannesen, et al.. (2018). Assessment of Multi‐Ion Channel Block in a Phase I Randomized Study Design: Results of the CiPA Phase I ECG Biomarker Validation Study. Clinical Pharmacology & Therapeutics. 105(4). 943–953. 59 indexed citations

12.

Kinrade, Sally, Jay W. Mason, Carlos Sanabria, et al.. (2018). Evaluation of the Cardiac Safety of Long‐Acting Endectocide Moxidectin in a Randomized Concentration‐QT Study. Clinical and Translational Science. 11(6). 582–589. 11 indexed citations

13.

Greene, Spencer, Patrick K. Noonan, Carlos Sanabria, & W. Frank Peacock. (2016). Effervescent N-Acetylcysteine Tablets versus Oral Solution N-Acetylcysteine in Fasting Healthy Adults: An Open-Label, Randomized, Single-Dose, Crossover, Relative Bioavailability Study. Current Therapeutic Research. 83. 1–7. 18 indexed citations

14.

Mason, Jay W., et al.. (2016). Electrocardiographic Effects of a Supratherapeutic Dose of Oritavancin. Clinical Pharmacology in Drug Development. 5(6). 502–508. 3 indexed citations

15.

Bellibas, S. Eralp, et al.. (2016). Lack of Effect of Oritavancin on Warfarin Pharmacokinetics in Healthy Adult Subjects. Open Forum Infectious Diseases. 3(suppl_1). 1 indexed citations

16.

Johannesen, Lars, José Vicente, Mason Jw, et al.. (2015). Late sodium current block for drug‐induced long QT syndrome: Results from a prospective clinical trial. Clinical Pharmacology & Therapeutics. 99(2). 214–223. 107 indexed citations

17.

Donovan, Joanne M., Maria Mancini, Carlos Sanabria, & Michael R. Jirousek. (2015). Phase 1 Study of CAT-2054, an Oral Novel Modulator of SREBP. Journal of clinical lipidology. 9(3). 474–475. 3 indexed citations

18.

Johannesen, Lars, José Vicente, Jay W. Mason, et al.. (2014). Differentiating Drug-Induced Multichannel Block on the Electrocardiogram: Randomized Study of Dofetilide, Quinidine, Ranolazine, and Verapamil. Clinical Pharmacology & Therapeutics. 96(5). 549–558. 203 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact